Asthma
Conditions
Keywords
Asthma
Brief summary
This project seeks to test and refine an adapted/expanded version of a previously created ASTHMAXcel app.
Detailed description
The study will test the adapted app on participants ages 15-21 (recruited from outpatient primary and specialty care sites at Montefiore) with asthma, for a period of 4 and a half months, and will conduct formative and summative evaluation of the application's functionality and usability. The investigators will also be collecting process and clinical outcomes.
Interventions
ASTHMAXcel includes interactive games, educational videos, quizzes and personalized feedback to teach different aspects of asthma management.
Sponsors
Study design
Intervention model description
Study will eventually compare health outcomes between a group given the ASTHMAXcel intervention and a group given Usual Care
Eligibility
Inclusion criteria
* English-speaking individuals between 15-21 * Persistent asthma (diagnosis made by a healthcare provider) * On a daily controller medication * Able to give informed consent * Smartphone (iOS or Android) access
Exclusion criteria
* Use of oral corticosteroids in the 2 weeks prior to the baseline visit * Pregnancy * Severe psychiatric or cognitive problems that would prohibit an individual from understanding and completing the protocol * Patients that previously received the ASTHMA-Educator application
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change from Baseline Asthma Control to 3 Month Asthma Control | Post-Refinement Baseline, 3 Months | Asthma symptom burden as measured by the Asthma Control Test Score Scale: 5 (min = worse); 25 (max = better outcome) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Asthma Knowledge | Post-Refinement Baseline, 3 Month | Will use the Child Asthma Illness Representation Survey (AIRS) to asses patients knowledge on asthma as well as their attitudes towards their condition. Score Scale: 4 (min = worse outcome); 20 (max = better outcome) |
| Medication Adherence | Post-Refinement Baseline, 3 Month | Self-reported adherence by patient using Medication Adherence Report Scale Score Scale: 10 (min = worse outcome); 50 (max = better outcome) |
| Asthma Quality of Life | Post-Refinement Baseline, 3 Month | Quality of life of participants, measured by mini-Asthma Quality of Life Questionnaire Score Scale: 15 (min = worse outcome); 105 (max = better outcome) |
| Emergency Department Visits | Post-Refinement Baseline, 3 Month | Self-Reported Emergency Department (ED) visits |
| Asthma Symptom Perception | Week 2, Week 4 , Week 6 (Pre and Post Refinement) | Ability of participants to perceive their asthma symptoms by using the ASTHMAXcel app and a peak flowmeter |
| Patient Interface Satisfaction | Post-Refinement Baseline, 3 Month | Patient satisfaction with ASTHMAXcel app interface measured by Questionnaire for User Interface Survey (QUIS) Score Scale: 0 (min = worse outcome); 261 (max = better outcome) Answers scale from 0 (terrible/hard to understand)) to 9 (wonderful/easy to understand) |
| Patient Usage | Baseline, 3 Month | Time spent on app and different screens of app, measured using Google Analytics |
| Health Literacy | Post-Refinement Baseline | Ability for patients to comprehend Newest Vital Sign screening tool |
| Patient Satisfaction | Post-Refinement Baseline, 3 Month | Patient satisfaction with study measured by the Client Satisfaction Questionnaire-8 Score Scale: 8 (min = worse outcome); 32 (max = better outcome) |
Countries
United States